Societe Generale’s Bausch Health BHC Stock Holding History

Societe Generale’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$437K	Buy	+21,687	New	+$614K	﹤0.01%	1771

Other funds holding BHC

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Societe Generale's BHC Position: Q2 2016 in Review

Societe Generale opened a new position in Bausch Health (BHC) in Q2 2016: 21,687 shares worth $437K. The stake represents ﹤0.01% of the portfolio and ranks #1771 among its holdings.

347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

Societe Generale held 21,687 shares of Bausch Health worth $437K as of Q2 2016.
Bausch Health was a new Societe Generale position in Q2 2016.
Bausch Health made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #1771 holding.
347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.